Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
American Journal of Hematology|October 9, 2019
Dissecting the web of ischemic stroke, sickle cell trait, and chronic kidney diseaseDonna Neuberg
Pediatric Blood & Cancer|September 30, 2017
Wrangling with P-valuesDonna Neuberg
Blood Advances|January 4, 2018
How many mice? Design considerations for murine studiesDonna Neuberg
Blood|June 22, 2013
When "rare" is no excuse for progressDonna Neuberg, Robert J Arceci
Statistics in Medicine|November 17, 2006
The statistical performance of an MCF-7 cell culture assay evaluated using generalized linear mixed models and a score testB Rey deCastro, Donna Neuberg
Journal of the American Statistical Association|March 1, 2012
Bayesian Hidden Markov Modeling of Array CGH DataSubharup Guha, Yi Li, Donna Neuberg
Thrombosis Research|June 12, 2012
Accounting for death as a competing risk in cancer-associated thrombosis studiesFederico Campigotto, Donna Neuberg, Jeffrey I Zwicker
Journal of Occupational and Environmental Medicine|June 24, 2004
Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype, and lung cancer riskLisa I Wang, Donna Neuberg, David C Christiani
Blood|July 30, 2017
Response: Making "perfect" the enemy of goodJason E Farrar, Donna Neuberg, Timothy Triche, et al.
Cancer|April 10, 2004
Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology GroupSanjiv S Agarwala, Donna Neuberg, Yuhyun Park, et al.
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
American Journal of Hematology|October 9, 2019
Dissecting the web of ischemic stroke, sickle cell trait, and chronic kidney diseaseDonna Neuberg
Pediatric Blood & Cancer|September 30, 2017
Wrangling with P-valuesDonna Neuberg
Blood Advances|January 4, 2018
How many mice? Design considerations for murine studiesDonna Neuberg
Blood|June 22, 2013
When "rare" is no excuse for progressDonna Neuberg, Robert J Arceci
Statistics in Medicine|November 17, 2006
The statistical performance of an MCF-7 cell culture assay evaluated using generalized linear mixed models and a score testB Rey deCastro, Donna Neuberg
Journal of the American Statistical Association|March 1, 2012
Bayesian Hidden Markov Modeling of Array CGH DataSubharup Guha, Yi Li, Donna Neuberg
Thrombosis Research|June 12, 2012
Accounting for death as a competing risk in cancer-associated thrombosis studiesFederico Campigotto, Donna Neuberg, Jeffrey I Zwicker
Journal of Occupational and Environmental Medicine|June 24, 2004
Asbestos exposure, manganese superoxide dismutase (MnSOD) genotype, and lung cancer riskLisa I Wang, Donna Neuberg, David C Christiani
Blood|July 30, 2017
Response: Making "perfect" the enemy of goodJason E Farrar, Donna Neuberg, Timothy Triche, et al.
Cancer|April 10, 2004
Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology GroupSanjiv S Agarwala, Donna Neuberg, Yuhyun Park, et al.
Pageof 36